| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.97M | 2.23M | 814.73K | 1.10M | 496.86K | 908.95K |
| Gross Profit | 936.82K | 1.12M | 481.73K | 89.00K | -253.40K | 64.50K |
| EBITDA | -30.32K | -85.26K | -789.23K | -203.66K | -588.36K | 651.44K |
| Net Income | 170.41K | -128.79K | -761.25K | -116.11K | -531.03K | 603.22K |
Balance Sheet | ||||||
| Total Assets | 2.11M | 1.61M | 1.81M | 1.99M | 2.16M | 2.82M |
| Cash, Cash Equivalents and Short-Term Investments | 213.17K | 530.89K | 1.03M | 1.14M | 1.83M | 2.48M |
| Total Debt | 162.84K | 201.94K | 301.05K | 288.77K | 277.32K | 485.00K |
| Total Liabilities | 1.04M | 703.85K | 776.75K | 755.20K | 810.53K | 863.95K |
| Stockholders Equity | 1.07M | 902.25K | 1.03M | 1.23M | 1.35M | 1.96M |
Cash Flow | ||||||
| Free Cash Flow | -316.10K | -395.68K | -547.36K | -443.06K | -632.93K | 423.19K |
| Operating Cash Flow | -286.76K | -358.46K | -530.67K | -414.60K | -630.80K | 423.59K |
| Investing Cash Flow | -31.48K | -35.07K | -16.68K | 23.19K | -499.00 | 12.07K |
| Financing Cash Flow | 112.35K | -99.11K | 417.03K | -241.96K | -21.18K | 1.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | AU$19.56M | 3.95 | 7.57% | ― | 28.91% | -1050.00% | |
44 Neutral | AU$9.49M | -0.96 | 152.58% | ― | -40.05% | -49.57% | |
44 Neutral | AU$10.57M | -2.48 | -578.72% | ― | 241.34% | 44.19% | |
43 Neutral | AU$32.26M | -4.21 | -52.26% | ― | -36.68% | 79.41% | |
42 Neutral | AU$1.75M | 2.94 | 17.24% | ― | 173.74% | 88.86% | |
42 Neutral | AU$4.12M | -1.98 | 20.02% | ― | -9.90% | 34.07% |
Oakridge International Limited reported a strong turnaround in its half-year results to 31 December 2025, with revenue from ordinary activities rising 61.9% to $1.79 million and profit after tax swinging from a loss of $126,968 to a profit of $172,239. The company’s net tangible asset backing per share improved to 3.98 cents from 3.35 cents, while the board opted not to declare a dividend, signaling a likely focus on reinvestment and balance sheet strength as it consolidates its improved performance.
The most recent analyst rating on (AU:OAK) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Oakridge Internatinal Ltd stock, see the AU:OAK Stock Forecast page.
Oakridge International reported a solid December 2025 quarter, driven by growing healthcare technology revenues, stronger customer orders and disciplined cost control, with A$619,000 in customer receipts for the period and A$1.204 million for the half year supporting increased investment in inventory to meet anticipated demand. The company advanced key product and technology initiatives, including completion of RTLS enablement for its core platform ahead of initial production shipments in early 2026, progress on NuCaMS Enterprise infrastructure and Single Sign On integration, and continued alignment with evolving nurse call standards, while maintaining a robust project pipeline across Australian and selected international markets through strong partner activity, multisite rollouts and expanded assisted living programs that are expected to underpin higher revenues over the remainder of FY2026.
The most recent analyst rating on (AU:OAK) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Oakridge Internatinal Ltd stock, see the AU:OAK Stock Forecast page.